Liposome in situ gelling system: Novel carrier based vaccine adjuvant for intranasal delivery of recombinant protein vaccine

Procedia in Vaccinology

Volumn 1, Issue 1, 2009, Pages 148-163

  Tiwari, Shailja ^a   Goyal, Amit K ^b   Mishra, Neeraj ^a   Vaidya, Bhuvaneshwar ^a   Mehta, Abhinav ^a   Dube, Devyani ^a   Vyas, Suresh P ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b ISF COLLEGE OF PHARMACY   (India)

Author keywords

antigen; HBsAg; Liposome in situ gelling system; Poly acrylic acid

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPID; LIPOSOME; POLYACRYLIC ACID; POLYMER; RECOMBINANT PROTEIN; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTATION; AQUEOUS SOLUTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FILM; FLUORESCENCE MICROSCOPY; GAMMA SCINTIGRAPHY; GEL; GELATION; HEPATITIS B; HUMORAL IMMUNITY; HYDRATION; IMMUNIZATION; IN VIVO STUDY; LIPOSOMAL DELIVERY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; NOSE MUCOSA; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

EID: 71549167983     PISSN: 1877282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.provac.2009.07.027     Document Type: Article

References (31)

1. Storni T., Kundig T.M., Senti G., and Johansen P. Immunity in response to particulate antigen-delivery systems. Advanced Drug Delivery Reviews 57 3 (2005) 333-355
2. Harding C.V., Collins D.S., and Kanagawa O. Liposome encapsulated antigen engender lysosome processing for class II MHC presentation and cytosolic processing for class I presentation. J Immunol. 147 (1991) 2863
3. Frezard F. Liposomes: From biophysics to the design of peptide vaccine. Braz J Med Biol Res 32 (1999) 181-189
4. Gregoriadis G., McCormack B., Obrenovic M., Saffie R., Zadi B., and Perrie Y. Vaccine entrapment in liposomes. Methods 19 (1999) 156-162
5. Dai C., Wang B., Zhao H., Li B., and Wang J. Preparation and characterization of liposomes-in-alginate (LIA) for protein delivery system. Colloids and Surfaces B: Biointerfaces 47 (2006) 205-210
6. Huang C. Studies on phosphatidylcholine vesicles: formation and physical characteristics. Biochemistry 8 1 (1969) 344-352
7. Bangham A.D., Standish N.M., and Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology 13 (1965) 238-252
8. Bangham A.D. Lipid bilayers and biomembranes. Annu. Rev. Biochem 41 (1972) 753-776
9. Gariépy E.R., Leclair G., Gupta A., and Leroux J.C. Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. Journal of Controlled Release 21 (2002) 373-383 Hildgenhttp://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T3D-46H6X2N-7&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=6844bc30603cde639b2ef6bcfe4fc271 - aff2#aff2
10. Tiwari S., Goyal A.K., Khatri K., Mishra N., and Vyas S.P. Gel core liposomes: An advanced carrier for improved vaccine delivery. Journal of Microencapsulation 26 1 (2009) 75-82
11. Robinson J.R., Longer M.A., and Veillard M. Bioadhesive polymers for controlled drug delivery. Ann N Y Acad Sci 507 (1987) 307-314
12. Mortazavi S.A. An in vitro assessment of mucus mucoadhesive interactions. Int J Pharm 124 (1995) 173-182
13. Dittgen M., Durrani M., and Lehmann K. Acrylic polymers. A review of pharmaceutical applications. S. T. P. Pharma Sci 7 (1997) 403-437
14. Nossal J.V. The global alliance for vaccines and immunization-a millennial challenge. Nat Immunol 1 (2000) 5-8
15. McGhee JR, Lamm ME, Strober W. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J. Mucosal immune responses. Mucosal immunology, 2 (1999) 485-506.
16. Davis S.S. Nasal vaccines. Adv Drug Deliv Rev 51 (2001) 21-42
17. Partidos C.D. Intranasal vaccines: forthcoming challenges. Pharm Sci Technol Today 3 (2000) 273-280
18. Shuliang L., Jonathan N., and Andre Francis P. Liposome-encapsulated actin-hemoglobin (LEAcHb) artificial blood substitutes. Biomaterials 26 (2005) 3759-3769
19. Jaganathan K.S., and Vyas S.P. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally. Vaccine 24 (2006) 4201-4211
20. Goyal A.K., Rawat A., Mahor S., Gupta P.N., Khatri K., and Vyas S.P. Pharmaceutical NanotechnologyNanodecoy system: A novel approach to design hepatitis B vaccine for immunopotentiation. International Journal of Pharmaceutics 309 (2006) 227-233
21. Florindo H.F., Pandit S., Lacerda L., Gonçalves L.M.D., Alpar H.O., and Almeida A.J. The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-3-caprolactone-based nanoparticles. Biomaterials 30 (2009) 879-891
22. Florindo H.F., Pandit S., Goncalves L.M., Alpar H.O., and Almeida A.J. S. equi antigens adsorbed onto surface modified poly-caprolactone microspheres induce humoral and cellular specific immune responses. Vaccine 26 (2008) 4168-4177
23. Khatri K., Goyal A.K., Gupta P.N., Mishra N., Mehta A., and Vyas S.P. Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine 26 (2008) 2225-2233
24. Soane R.J., Hinchcliffe M., Davis S.S., and Illum L. Clearance characteristics of chitosan based formulations in the sheep nasal cavity. Int J Pharm 217 (2001) 183-191
25. Debin A., Kravtzoff R., Santiago J.V., Cazales L., Sperandio S., and Melber K. Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses. Vaccine 20 (2002) 2752-2763
26. Jain S., Singh P., Mishra V., and Vyas S.P. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against Hepatitis B. Immunol Lett 101 (2005) 41-49
27. Florindo H.F., Pandit S., Goncalves L.M., Alpar H.O., and Almeida A.J. S. equi antigens adsorbed onto surface modified poly-caprolactone microspheres induce humoral and cellular specific immune responses. Vaccine 26 (2008) 4168-4177
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
29. Almeida AJ, Alpar HO. Mucosal immunisation with antigen-containing microparticles. Antigen delivery systems: immunological and technological issues. (1997) 207-226.
30. Szakal A.K., Burton G.F., Smith J.P., and Tew J.G. Antigen processing and presentation in vivo. Topics in vaccine adjuvant research (2001) 11-21
31. Benoit M.A., Baras B., and Gillard J. Preparation and characterization of proteinloaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. Int J Pharm 184 (1999) 73-84